Skip to content

Study on the effects of long-term intervention of a home robots on stress reduction.

Study on the effects of long-term intervention of a home robots on stress reduction. - Study on long-term stress-relieving effects of a home robots

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047594
Enrollment
10
Registered
2022-04-26
Start date
2022-05-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Subjects spend 15 minutes with the home robot &quot
LOVOT(R)&quot
(GROOVE X Co., Ltd.) before bedtime every day for six weeks. Saliva sampling and autonomic nerve balance measurement based on pulse wave fluctuations using the acceleration pulse wave measuring device
TAS9 VIWE RW&quot
(YKC Co., Ltd.) are conducted three times a week (Monday, Wednesday, Friday), and a questionnaire survey on mental state using the Visual Analog Scale (VAS) is conducted once a week (Wednesday).

Sponsors

Tokyo University of Pharmacy and Life Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subjects aged 18 to 65 at the time of consent. 2) Subjects who have been informed of the contents of this study and have confirmed their consent in the consent form.

Exclusion criteria

Exclusion criteria: 1) Subjects with a diagnosis of arrhythmia 2) Subjects who have a cardiac pacemaker. 3) Subjects who currently smoke on a daily.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS) values of subjective mental changes (I feel irritated, I have worries, I feel tense, I feel nervous, I have anxiety, I am depressed.)

Secondary

MeasureTime frame
1) Concentration of physiologically active substances in saliva (oxytocin, secretory immunoglobulin A (s-IgA)) 2) Autonomic balance index based on pulse wave (heart rate) variability analysis

Countries

Japan

Contacts

Public ContactSadahiko Shimoeda

Tokyo University of Pharmacy and Life Sciences Department of Pharmacy Pharmaceutical Care and Sciences

shimoeda@toyaku.ac.jp042-676-6697

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026